Medical Technology Company

 

We are experienced professionals in the medical trade that invest in, innovate on and develop medical technology assets for strategic transfers to larger firms that can more efficiently commercialize at scale. 

The financial investors behind the firm are private and marquis, also being long standing members of The World’s Billionaires List as annually published by Forbes. 

The operational team is led by technology transfer and IP licensing specialists with decades of expertise in the field, having excelled at successfully setting up, replicating and operating multiple manufacturing plants across the globe for the likes of Motorola, Nasdaq listed Citrix Systems (NQ: CTXS) and Boca Research. 

Current investments focus around platform technologies for active implantable medical device (AIMD) systems. One of our prized investments are the assets acquired and further developed to service this burgeoning $14B+ industry vertical.

CRM ‘Product Technology’ Assets

Through transfer of technology protocol the firm setup independent manufacturing operations in 2007 in Bangalore, India. Through this technology over 40,000 implantable cardiac pacemaker systems have been produced and distributed over the past three decades across Latin America, The Indian sub-continent, Asia, The GCC and MENA region, Greek & Balkan States, Eastern Europe and other such CE accepting nations. This CRM product is well positioned to be the ‘value segment’ leader across the emerging markets. 

Per WHO Cardiac Arrhythmia is the single largest therapeutic area which remains undeserved across the emerging markets. The Cardiac Rhythm Management (CRM) technology developed to efficiently detect and treat arrythmia is well designed and positioned to serve this burgeon market. 

The products meet the highest industry standard’s of Quality and Regulatory approvals – the products are CE Certified by BSI and the Quality Systems are ISO 13485-9001 Compliant and Certified to Class III Standards. The system complies with FDA Standards for both export only and domestic distribution. 

AIMD ‘Process Technology’ Assets

The South American technology provider CCC del Uruguay [Now part of Integer Medical] holds the Gold Standard in the Intellectual Property know-how for the design, development , production and testing of AIMD systems. Under a Transfer of Technology with CCC in 2007, these Intellectual Property assets along with the custom fabricated capital equipment required to assemble, test and manufacture active implantable medical device systems was executed enabling independent operations. 

The firm today is empowered with unrestricted global rights to manufacture, innovate on and market the platform system [including the Implantable Pulse Generator (IPG), pacing lead electrodes and wireless handheld programming systems] as currently used across lead electrode based stimulation therapy systems. 

Through strategic partnership(s) we now bring this established technology to North America. With this we seek to further empower certain established North American medical manufacturing and design development companies by providing an excellent global sourcing supply chain along with the technical know-how, Intellectual Property and capital assets required to efficiently and reliably box-build the Class III grade AIMD Platform System (IPG, Lead Electrodes, Programmer) used across Neuromodulation applications. 

Relevant parties may establish contact at: admin@medived.com

 

Video On Pacemaker Production 

 

The link showcases a virtual tour of the AIMD manufacturing plant setup under Technology Transfer protocol.